H2‐P, a honokiol derivative, exerts anti‐angiogenesis effects via c‐MYC signaling pathway in glioblastoma
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.26462
Abstract: H2‐P, a derivative of honokiol, was first synthesized in our laboratory. Compared with honokiol, H2‐P has even high anti‐tumor activity. In the present study, we evaluated the ability of H2‐P to inhibit the survival rate… read more here.
Keywords: via myc; anti angiogenesis; angiogenesis; myc signaling ... See more keywords
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer letters"
DOI: 10.1016/j.canlet.2020.12.019
Abstract: Lipid metabolic reprogramming plays a pivotal role in hepatocellular carcinoma (HCC) development, but the underlying mechanisms are incompletely characterized. Long chain acyl CoA synthetase 4 (ACSL4), a member of acyl-CoA synthetases (ACS) family, has been… read more here.
Keywords: hepatocellular carcinoma; via myc; hcc; metabolism ... See more keywords
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of cellular and molecular medicine"
DOI: 10.1111/jcmm.17322
Abstract: Aerobic glycolysis is a well-known hallmark of hepatocellular carcinoma (HCC). Hence, targeting the key enzymes of this pathway is considered a novel approach to HCC treatment. The effects of sodium butyrate (NaBu), a sodium salt… read more here.
Keywords: hcc; butyrate; via myc; hcc cells ... See more keywords